Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Judd

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Children'S Orthopaedics|October 28, 2024
Pre-operative Gallows traction as an adjunct to hip open reduction surgery: Is it safe and is it effective?Nicholas C Uren, Julia Judd, Edward A Lindisfarne, et al.
Journal of Children'S Orthopaedics|April 3, 2024
Preoperative Gallows traction as an adjunct to hip open reduction surgery: Is it safe and is it effective?Nicholas C Uren, Julia Judd, Edward A Lindisfarne, et al.
Journal of Pediatric Orthopedics|March 19, 2015
Vitamin D Deficiency in Slipped Upper Femoral Epiphysis: Time to Physeal FusionJulia Judd, Rachel Welch, Anna Clarke, et al.
Head & Neck|May 13, 2022
Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancerKevin K Zarrabi, Thomas J Galloway, Douglas B Flieder, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 29, 2016
Low Level of Blood CD4<sup>+</sup> T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell LymphomaJulia Judd, Essel Dulaimi, Tianyu Li, et al.
International Journal of Orthopaedic and Trauma Nursing|June 6, 2020
Updating the UK competence framework for orthopaedic and trauma nurses 2019Julia Judd, Karen Barnard, Sonya Clarke, et al.
The Oncologist|June 28, 2017
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 InhibitorsJulia Judd, Matthew Zibelman, Elizabeth Handorf, et al.
International Journal of Molecular Sciences|November 14, 2023
Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen SequencingSandra V Fernandez, Yin Fei Tan, Shilpa Rao, et al.
Molecular Cancer Therapeutics|September 14, 2021
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung CancerJulia Judd, Nagla Abdel Karim, Hina Khan, et al.
JCO Precision Oncology|February 8, 2024
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non-Small-Cell Lung CancerAbdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Children'S Orthopaedics|October 28, 2024
Pre-operative Gallows traction as an adjunct to hip open reduction surgery: Is it safe and is it effective?Nicholas C Uren, Julia Judd, Edward A Lindisfarne, et al.
Journal of Children'S Orthopaedics|April 3, 2024
Preoperative Gallows traction as an adjunct to hip open reduction surgery: Is it safe and is it effective?Nicholas C Uren, Julia Judd, Edward A Lindisfarne, et al.
Journal of Pediatric Orthopedics|March 19, 2015
Vitamin D Deficiency in Slipped Upper Femoral Epiphysis: Time to Physeal FusionJulia Judd, Rachel Welch, Anna Clarke, et al.
Head & Neck|May 13, 2022
Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancerKevin K Zarrabi, Thomas J Galloway, Douglas B Flieder, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 29, 2016
Low Level of Blood CD4<sup>+</sup> T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell LymphomaJulia Judd, Essel Dulaimi, Tianyu Li, et al.
International Journal of Orthopaedic and Trauma Nursing|June 6, 2020
Updating the UK competence framework for orthopaedic and trauma nurses 2019Julia Judd, Karen Barnard, Sonya Clarke, et al.
The Oncologist|June 28, 2017
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 InhibitorsJulia Judd, Matthew Zibelman, Elizabeth Handorf, et al.
International Journal of Molecular Sciences|November 14, 2023
Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen SequencingSandra V Fernandez, Yin Fei Tan, Shilpa Rao, et al.
Molecular Cancer Therapeutics|September 14, 2021
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung CancerJulia Judd, Nagla Abdel Karim, Hina Khan, et al.
JCO Precision Oncology|February 8, 2024
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non-Small-Cell Lung CancerAbdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.
Pageof 3